Author

A. Bataller

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:scRNA-seq· 2 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

C. Bueno· 2 shared H. Heyn· 2 shared J. L. Trincado· 2 shared P. Menendez· 2 shared A. Closa· 1 shared A. M. Garcia-Sancho· 1 shared A. Orfao· 1 shared A. Rill-Hinarejos· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. Bueno

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Integrative single-cell multi-omics of CD19CARpos and CARneg T cells suggest drivers of immunotherapy response in B-cell neoplasias

M. Guerrero-Murillo, A. Rill-Hinarejos, J. L. Trincado, A. Bataller, V. Ortiz-Maldonado, D. Benitez-Ribas, M. Espanol, E. A. Gonzalez, N. Martinez-Cibrian, D. Marchese, L. Martin-Martin, A. M. Garcia-Sancho, H. Heyn, M. Juan, A. Urbano-Ispizua, , P. Menendez

This study integrates single-cell multi-omics data from CAR-T cells to identify factors influencing immunotherapy response in B-cell neoplasias.

bioRxiv · Jan 23, 2024 · PreprintImmunology

A comprehensive single-cell expression atlas of human AML leukemia-initiating cells unravels the contribution of HIF pathway and its therapeutic potential

T. Velasco-Hernandez, J. L. Trincado, M. Vinyoles, A. Closa, F. Gutierrez-Aguera, O. Molina, V. C. Rodriguez-Cortez, P. Petazzi, S. Beneyto-Calabuig, L. Velten, P. Romecin, R. Casquero, F. Abollo-Jimenez, R. Diaz de la Guardia, P. Lorden, , P. Menendez

The paper creates a single-cell atlas of AML leukemia-initiating cells and shows that targeting the HIF pathway enhances chemotherapy effectiveness against these cells.

bioRxiv · Mar 2, 2022 · PreprintCancer Biology